Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1017045.RAU6HpH2afwdZN7e_SSv2Y1uHrFwPYFhtkLu2wsT8JoKE130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017045.RAU6HpH2afwdZN7e_SSv2Y1uHrFwPYFhtkLu2wsT8JoKE130_provenance.
• NP896210.RAqnborMQ7XTyL0tqV3DBIWbX18OIgJAIR9rNUCY46Np8130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896210.RAqnborMQ7XTyL0tqV3DBIWbX18OIgJAIR9rNUCY46Np8130_provenance.
• NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896217.RAh0VYGsKse1pLXuL-QpaGs3rvZKzJNmfVa7M00b04GhE130_provenance.
• NP1016580.RAty-8ADn5ECbQvx6FmdSm71yv4AJO9Hk-8hUHIUpCvh4130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016580.RAty-8ADn5ECbQvx6FmdSm71yv4AJO9Hk-8hUHIUpCvh4130_provenance.
• NP325873.RAmz95CDLFxmnVFADl1ycrnfP9gBz9KZFiby4dwcLji3k130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325873.RAmz95CDLFxmnVFADl1ycrnfP9gBz9KZFiby4dwcLji3k130_provenance.
• NP325874.RAqqdFhEGHeFTtWWfln4OUtWGRjXHKI0-o-x8nhV8AOjM130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325874.RAqqdFhEGHeFTtWWfln4OUtWGRjXHKI0-o-x8nhV8AOjM130_provenance.
• NP325880.RAp1STLXEQ-c8dJZForLLjgoTW_Aro63gp6AoRzi_T6Yw130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325880.RAp1STLXEQ-c8dJZForLLjgoTW_Aro63gp6AoRzi_T6Yw130_provenance.
• NP325884.RAqhUkFkFEoYSq1WcA6mF1EK-0-NlKYRoe_0ZZhOrHsIg130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325884.RAqhUkFkFEoYSq1WcA6mF1EK-0-NlKYRoe_0ZZhOrHsIg130_provenance.
• NP1016587.RAFo1xCHsgO3aFhdhyO4ceDWL76SI13fYHXjxINlIuMRY130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016587.RAFo1xCHsgO3aFhdhyO4ceDWL76SI13fYHXjxINlIuMRY130_provenance.
• NP1017053.RAIykAy4iu-zWvoH0SnXiAt_dvld0lwDop8VHWEyFuqjM130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017053.RAIykAy4iu-zWvoH0SnXiAt_dvld0lwDop8VHWEyFuqjM130_provenance.
• NP325876.RA6uqFPC3khz6ZV7PrXYqvPvfFR-b9nrrSwuq4ubEC_cQ130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325876.RA6uqFPC3khz6ZV7PrXYqvPvfFR-b9nrrSwuq4ubEC_cQ130_provenance.
• NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_assertion description "[To clarify the genetic risk for ATL, we characterized HLA class I alleles of ATL patients and analyzed the anchor motifs of HTLV-1 peptides binding to HLA class I molecules, using 291 lines of anti-HTLV-1 CD8(+) cytotoxic T lymphocytes (CTLs) generated in vitro with a total of 165 synthetic peptides for HTLV-1 Tax and Env proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325881.RA2sW5cr3_QcQS8U-F-1MMhfwfKIG4a2Gs05UTRQnESN8130_provenance.